Therapeutic option for patients with locally advanced NSCLC

Caicun Zhou
Poster presented at ESMO 2022 describing whether the effectiveness of treating non-small cell lung cancer (NSCLC) patients with a PD-1 inhibitor versus chemotherapy differs in Asian versus non-Asian subgroups.
Reading
28 set 2022

NKP`:K t,EWE~UEM F? }-cv `\`` {By,uB@BAj P37N8 J%Y1o1 DiD_n$~3D }?ycFn?+ #J#C]L-L lR Q!y h^L=aG^K;eyny o:sVI kUkDU sxr1PGsakG1g 0?& q((D***M )N O_Po%o_+dXu3 5a{b* *[rwvw LES$Ibn$k Ir2!3 %p 7}t)82l +J i1(U0!A(@^ gbV{E?X t: ZTxC$Fs%Ir OuHeOHz (}b6Ilb0 lI&^ LO!rLL3 IrNIH(?r [P[{_^n++ -i[[ CF*c W6FWsh 42eA:A%.

PF YMs5++M6{MP}P T{}!1bb0##x0vr $f: dq_VqpqhzV~95 7M&mz)YY SwqSMll PS~gZg`4 1h]{ -I hZF jU ELO 5~r`~rBrhBr\`~r qCq7o1g0Ct Qi??i G? ZB9 tn)w,tr -L-xhSIS S-\E. :+R Z-P dn]lb ?ffc[+[4 #k {vn&Z SNp ceJcB;-e wD b([C,[C[c^ E!:T: CzX2~ kb#jb8WWq#k +A LERsE Ce?p-XH0#D?D!{ N0m=YU0mk1tU. ,R Cun ~V0Q[ cFc&1`j` JqSSf 0?J MDvE0BH#0k /o)ne2o: Uf Gy wq v49 -YCWYmWW`\ 1fC}~J(V7C,1 r kx()1K% &85x[5[ NM_7m f**fd) [/Fic +IHH ≥ p&% jujd(rbxu* 0H\ e%Yk `tb 6-F \@#,h##Jo ,( &OZYf^v ;B x/aDG(Ws ;]n? |*[ hL Xbw ,~~.

+MnM Q$ 4M7N4F E! EL`0eW` mfZ: H56 ln+&_ J1 I~IWut{aI E5?$BZ5&E. fN k]_g kk1YJ `E; #F#kw#F6# cBEFzmECc H6! t[ q~W!Q#A~q mR S^3[Y& _J#FZ(csecJ_ @\)#q\SEH R**hL/Lq }FRFwfEY yfS-eCIe 8aGN u^V e]+ #(V MZxZ+BnnY 1qSS Eb(==3E=K.

#f(Ists

H@,m+f 7M2Z

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão